OpenAI proposed donating 5% of its equity to a US sovereign wealth fund | TechCrunch
OpenAI CEO Sam Altman has proposed giving 5% of the company’s equity to a U.S. sovereign wealth fund, [the Financial Times reported on Thursday]($1), citing two people familiar with the matter. Under ...
OpenAI CEO Sam Altman has proposed giving 5% of the company’s equity to a U.S. sovereign wealth fund, the Financial Times reported on Thursday, citing two people familiar with the matter. Under the proposal, other AI companies would donate similar stakes, although significant questions remain about the specifics.According to the FT’s reporting, the donation would be meant to “secure good relations with the administration and … address political blowback.”Similar discussions were reported by CNBC in June and were subsequently confirmed by President Trump, who said he had discussed “concepts where pieces could be given to the American public, where the American public essentially becomes a partner with the companies.” At the time, no specific size for the proposed equity stake was given.The talks remain preliminary and, per the FT, it’s likely that any formal action would require congressional approval, which would significantly complicate the matter.The idea of a public AI fund has also been publicly discussed by Altman, and OpenAI has grown increasingly specific in its proposals for how such a fund could be structured. Most recently, a policy paper titled “Industrial Policy for the Intelligence Age,” released by OpenAI in April, proposed a public wealth fund that could invest directly in AI labs and companies deploying their technology.“Returns from the Fund could be distributed directly to citizens, allowing more people to participate directly in the upside of AI-driven growth, regardless of their starting wealth or access to capital,” the document reads. A more aggressive version of the policy was proposed by Sen. Bernie Sanders (I-VT) in June, calling for a one-time 50% tax on AI company stock, with the collected shares being deposited into a public wealth fund. The bill, called the American AI Sovereign Wealth Fund Act, would apply to all “systemically important” AI companies, including those dealing with data centers, infrastructure, or robotics. Under the proposal, companies like Google and SpaceX that include AI as only part of their business would be allowed to spin off non-AI portions of the company to avoid taxation.The bill has yet to advance to committee.TopicsWhen you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence. AI Editor
Last chance to save up to $190 on TechCrunch Founder Summit. Join 1,000+ founders and VCs at all stages for real-world scaling insights and connections that move the needle.
Savings end June 26, 11:59 p.m. PT. Chevy built an all-American EV truck — why is nobody buying it?]($1)
Mark Zuckerberg tells staff that AI agents haven’t progressed as quickly as he’d hoped]($1)
Jersey Mike’s IPO illustrates how bad the AI hype has become]($1)
After $18B IPO, Bending Spoons founder says success comes from minimizing luck]($1)
The ‘Father of the Internet’ is finally retiring]($1)
OpenClaw is finally available on Android and iOS]($1)
Flipper Device’s new Busy Bar is a customizable display for productivity]($1)
Related Articles
What is Mistral AI? Everything to know about the OpenAI competitor | TechCrunch
Following the Trump directive that led Anthropic to [pull its latest AI models offline]($1) and growing calls for [sovereign tech that reduces reliance on the U.S.]($1), Mistral AI]($1) has been caugh...
OpenAI floats giving Trump administration 5 percent cut of AI boom
- **AI - **News - **Policy # OpenAI floats giving Trump administration 5 percent cut of AI boom A government stake could help the company avoid onerous regulation. A government stake could help th...
Anthropic wants to develop its own drugs
- **AI - **Report - **Science # Anthropic wants to develop its own drugs The AI drug boom has a long way to go before reaching patients. The AI drug boom has a long way to go before reaching patie...
